These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 2027300
21. Preferential suppression of low molecular weight natural tumor suppressor of human fetal liver origin on the growth of leukemic cells in vitro. Pei XT, Wu CT. Exp Hematol; 1990 Sep; 18(8):927-31. PubMed ID: 2387343 [Abstract] [Full Text] [Related]
22. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D, Strife A, Atzpodien J, Clarkson BD. Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231 [Abstract] [Full Text] [Related]
23. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells. Lagneaux L, Marie JP, Delforge A, Socquet M, Thevenin D, Zittoun R, Stryckmans P. Exp Hematol; 1989 Aug 15; 17(7):843-6. PubMed ID: 2753092 [Abstract] [Full Text] [Related]
24. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S. Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941 [Abstract] [Full Text] [Related]
25. The role of methylcellulose on colony growth of human myeloid leukemic progenitors (AML-CFU). Allieri MA, Douay L, Deloux J, Smadja N, Najman A, Gorin NC. Exp Hematol; 1990 Sep 15; 18(8):911-5. PubMed ID: 2387341 [Abstract] [Full Text] [Related]
27. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM). Grant S, Pettit GR, McCrady C. Exp Hematol; 1992 Jan 15; 20(1):34-42. PubMed ID: 1374343 [Abstract] [Full Text] [Related]
31. Discordant maturation as the primary biological defect in chronic myelogenous leukemia. Strife A, Lambek C, Wisniewski D, Wachter M, Gulati SC, Clarkson BD. Cancer Res; 1988 Feb 15; 48(4):1035-41. PubMed ID: 3422181 [Abstract] [Full Text] [Related]
32. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells. Grant S, Traylor R, Bhalla K, McCrady C, Pettit GR. Leukemia; 1992 May 15; 6(5):432-9. PubMed ID: 1593908 [Abstract] [Full Text] [Related]
33. Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state. Minderman H, Linssen P, van der Lely N, Wessels J, Boezeman J, de Witte T, Haanen C. Leukemia; 1994 Mar 15; 8(3):382-7. PubMed ID: 8127143 [Abstract] [Full Text] [Related]